Blood bank aims to predict leukemia risk in MDS patients

NCT ID NCT04869683

Recruiting now Knowledge-focused Sponsor: University Hospital, Brest Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study gathers blood and bone marrow samples from 150 adults with myelodysplastic syndrome (MDS), a blood disorder that can turn into acute leukemia. Researchers want to find biological markers that help predict which patients are likely to progress to leukemia. The goal is to better understand the disease and improve future treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors identify which patients with myelodysplastic syndrome are at higher risk of developing acute leukemia, leading to earlier monitoring or treatment.

What could go wrong

This is an observational study that collects samples for future research, not a treatment trial. It may not directly lead to new therapies or change patient care in the short term.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia with multilineage dysplasia chromosomal disorder Chromosome Aberrations myelodysplastic syndrome myelodysplastic syndrome associated with isolated del(5q) myelodysplastic syndrome with ring sideroblasts Myelodysplastic Syndromes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYELOID LEUKEMIA WITH MULTILINEAGE DYSPLASIA CHROMOSOME ABNORMALITY MYELODYSPLASTIC ANEMIA MYELODYSPLASTIC SYNDROME WITH ISOLATED DEL(5Q) MYELODYSPLASTIC SYNDROME WITH RING SIDEROBLASTS MYELODYSPLASTIC SYNDROMES

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Chu Brest
RECRUITING

Brest, 29609, France

Contact